Author

Lorena García‐Hevia

Instituto de Investigación Marqués de ValdecillaORCID 0000-0001-8275-7733Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Assay:metagenomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Mónica L. FanárragaiD· 2 shared Ana Márquez‐LópeziD· 1 shared Andrés Ramos‐ValleiD· 1 shared Anna Maria AviñóiD· 1 shared Arnau DomíngueziD· 1 shared Carme FàbregaiD· 1 shared Débora Muñoz-GuerraiD· 1 shared Natalia NavarroiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Mónica L. FanárragaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintFeb 16, 2026

Magnetic nanobiopsy: A minimal technology for live cell biomolecular sampling

Lorena García‐Hevia, Débora Muñoz-Guerra, Mónica L. Fanárraga

This paper introduces magnetic nanobiopsy, a non-destructive method for longitudinal molecular sampling from living cells, revealing cellular heterogeneity and dynamic molecular states.

DOI 10.64898/2026.02.15.705970

proteomicsmetagenomics

𝕏 PostBluesky

BioengineeringSmallPeer-reviewedApr 21, 2025

Targeted Tumor Microenvironment Delivery of Floxuridine Prodrug via Soluble Silica Nanoparticles in Malignant Melanoma as a Model for Aggressive Cancer Treatment

Andrés Ramos‐Valle, Arnau Domínguez, Natalia Navarro…·Mónica L. Fanárraga

This paper develops a targeted drug delivery system using silica nanoparticles to deliver a floxuridine prodrug, achieving significant tumor reduction in melanoma models.

5 citations

mouseexperimental assay

𝕏 PostBluesky